The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage.
Perilymphatic fistula is defined as an abnormal communication between the perilymph-filled space and the middle ear, or cranial spaces. The manifestations include a broad spectrum of neuro-otological symptoms such as hearing loss, vertigo/dizziness, disequilibrium, aural fullness, tinnitus, and cogn...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5788340?pdf=render |
| _version_ | 1818155750598377472 |
|---|---|
| author | Tetsuo Ikezono Tomohiro Matsumura Han Matsuda Satomi Shikaze Shiho Saitoh Susumu Shindo Setsuo Hasegawa Seung Ha Oh Yoshiaki Hagiwara Yasuo Ogawa Hiroshi Ogawa Hiroaki Sato Tetsuya Tono Ryuichiro Araki Yukihide Maeda Shin-Ichi Usami Yasuhiro Kase |
| author_facet | Tetsuo Ikezono Tomohiro Matsumura Han Matsuda Satomi Shikaze Shiho Saitoh Susumu Shindo Setsuo Hasegawa Seung Ha Oh Yoshiaki Hagiwara Yasuo Ogawa Hiroshi Ogawa Hiroaki Sato Tetsuya Tono Ryuichiro Araki Yukihide Maeda Shin-Ichi Usami Yasuhiro Kase |
| author_sort | Tetsuo Ikezono |
| collection | DOAJ |
| description | Perilymphatic fistula is defined as an abnormal communication between the perilymph-filled space and the middle ear, or cranial spaces. The manifestations include a broad spectrum of neuro-otological symptoms such as hearing loss, vertigo/dizziness, disequilibrium, aural fullness, tinnitus, and cognitive dysfunction. By sealing the fistula, perilymphatic fistula is a surgically correctable disease. Also, appropriate recognition and treatment of perilymphatic fistula can improve a patient's condition and hence the quality of life. However, the difficulty in making a definitive diagnosis due to the lack of an appropriate biomarker to detect perilymph leakage has caused a long-standing debate regarding its management. We have reported a clinical test for the diagnosis of perilymphatic fistula by detecting a perilymph specific protein, Cochlin-tomoprotein, as a diagnostic marker using a western blot. The aim of this study is to establish an ELISA-based human Cochlin-tomoprotein detection test and to evaluate its diagnostic accuracy in clinical subjects. The results of ELISA showed good dilution reproducibility. The mean concentration was 49.7±9.4 of 10 perilymph samples. The ROC curve in differentiating the perilymph leakage condition from the normal middle ear was significant (P < 0.001) with an area under the curve (AUC) of 0.918 (95% CI 0.824-0.100). We defined the diagnostic criteria as follows: CTP<0.4 negative; 0.4≦CTP<0.8 intermediate; 0.8≦CTP(ng/ml) positive in the clinical usage of the hCTP ELISA, and sensitivity and specificity were 86.4% and 100%, respectively. We further tested the expression specificity of the Cochlin-tomoprotein by testing blood and CSF samples. The concentration was below the detection limit (0.2 ng/ml) in 38 of the 40 blood, and 14 of the 19 CSF samples. We report the accuracy of this test for the diagnosis of perilymphatic fistula. Using ELISA, we can improve the throughput of the test. Furthermore, it is useful for a large-scale study to characterize the clinical picture and delineate the management of this medical condition. |
| first_indexed | 2024-12-11T14:47:22Z |
| format | Article |
| id | doaj.art-f6478d25fdad47e985571bed5aaeb615 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T14:47:22Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f6478d25fdad47e985571bed5aaeb6152022-12-22T01:01:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01131e019149810.1371/journal.pone.0191498The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage.Tetsuo IkezonoTomohiro MatsumuraHan MatsudaSatomi ShikazeShiho SaitohSusumu ShindoSetsuo HasegawaSeung Ha OhYoshiaki HagiwaraYasuo OgawaHiroshi OgawaHiroaki SatoTetsuya TonoRyuichiro ArakiYukihide MaedaShin-Ichi UsamiYasuhiro KasePerilymphatic fistula is defined as an abnormal communication between the perilymph-filled space and the middle ear, or cranial spaces. The manifestations include a broad spectrum of neuro-otological symptoms such as hearing loss, vertigo/dizziness, disequilibrium, aural fullness, tinnitus, and cognitive dysfunction. By sealing the fistula, perilymphatic fistula is a surgically correctable disease. Also, appropriate recognition and treatment of perilymphatic fistula can improve a patient's condition and hence the quality of life. However, the difficulty in making a definitive diagnosis due to the lack of an appropriate biomarker to detect perilymph leakage has caused a long-standing debate regarding its management. We have reported a clinical test for the diagnosis of perilymphatic fistula by detecting a perilymph specific protein, Cochlin-tomoprotein, as a diagnostic marker using a western blot. The aim of this study is to establish an ELISA-based human Cochlin-tomoprotein detection test and to evaluate its diagnostic accuracy in clinical subjects. The results of ELISA showed good dilution reproducibility. The mean concentration was 49.7±9.4 of 10 perilymph samples. The ROC curve in differentiating the perilymph leakage condition from the normal middle ear was significant (P < 0.001) with an area under the curve (AUC) of 0.918 (95% CI 0.824-0.100). We defined the diagnostic criteria as follows: CTP<0.4 negative; 0.4≦CTP<0.8 intermediate; 0.8≦CTP(ng/ml) positive in the clinical usage of the hCTP ELISA, and sensitivity and specificity were 86.4% and 100%, respectively. We further tested the expression specificity of the Cochlin-tomoprotein by testing blood and CSF samples. The concentration was below the detection limit (0.2 ng/ml) in 38 of the 40 blood, and 14 of the 19 CSF samples. We report the accuracy of this test for the diagnosis of perilymphatic fistula. Using ELISA, we can improve the throughput of the test. Furthermore, it is useful for a large-scale study to characterize the clinical picture and delineate the management of this medical condition.http://europepmc.org/articles/PMC5788340?pdf=render |
| spellingShingle | Tetsuo Ikezono Tomohiro Matsumura Han Matsuda Satomi Shikaze Shiho Saitoh Susumu Shindo Setsuo Hasegawa Seung Ha Oh Yoshiaki Hagiwara Yasuo Ogawa Hiroshi Ogawa Hiroaki Sato Tetsuya Tono Ryuichiro Araki Yukihide Maeda Shin-Ichi Usami Yasuhiro Kase The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. PLoS ONE |
| title | The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. |
| title_full | The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. |
| title_fullStr | The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. |
| title_full_unstemmed | The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. |
| title_short | The diagnostic performance of a novel ELISA for human CTP (Cochlin-tomoprotein) to detect perilymph leakage. |
| title_sort | diagnostic performance of a novel elisa for human ctp cochlin tomoprotein to detect perilymph leakage |
| url | http://europepmc.org/articles/PMC5788340?pdf=render |
| work_keys_str_mv | AT tetsuoikezono thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT tomohiromatsumura thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT hanmatsuda thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT satomishikaze thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT shihosaitoh thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT susumushindo thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT setsuohasegawa thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT seunghaoh thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yoshiakihagiwara thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yasuoogawa thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT hiroshiogawa thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT hiroakisato thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT tetsuyatono thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT ryuichiroaraki thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yukihidemaeda thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT shinichiusami thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yasuhirokase thediagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT tetsuoikezono diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT tomohiromatsumura diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT hanmatsuda diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT satomishikaze diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT shihosaitoh diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT susumushindo diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT setsuohasegawa diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT seunghaoh diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yoshiakihagiwara diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yasuoogawa diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT hiroshiogawa diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT hiroakisato diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT tetsuyatono diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT ryuichiroaraki diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yukihidemaeda diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT shinichiusami diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage AT yasuhirokase diagnosticperformanceofanovelelisaforhumanctpcochlintomoproteintodetectperilymphleakage |